Financial statements Orphinic Scientific
Balance sheet data of ORPHINIC SCIENTIFIC
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 8 314 597,44 | 9 694 226,41 | 27 720 256,74 |
| A. Fixed assets | 5 862 433,29 | 7 765 438,18 | 19 784 799,51 |
| B. Current assets | 2 452 164,15 | 1 928 788,23 | 7 935 457,23 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 8 314 597,44 | 9 694 226,41 | 27 720 256,74 |
| A. Equity | 7 864 824,24 | 8 326 442,14 | 27 417 671,97 |
| B. Liabilities and provisions for liabilities | 449 773,20 | 1 367 784,27 | 302 584,77 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 449 773,20 | 1 324 014,89 | 289 685,02 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.